InsidersTradesSigma
Explore the full record of transactions filed by Scadden David, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 3 disclosures have been logged. The latest transaction was disclosed on 20 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Scadden David serves as a Board Member at AGIOS PHARMACEUTICALS, INC. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the pharmaceutical sector.